drugset / Trial / NCT00028301

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301

Phase 3 Completed Bristol-Myers Squibb
Open-labelTreatment

Summary

This study will compare 2 treatments in the way they affect cholesterol levels and the amount of HIV in the blood.

Timeline

Start
2001-02
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified
Subject Lopinavir Other / unclassified
Subject Ritonavir Other / unclassified